Results 11 to 20 of about 95,516 (282)

Optimisation of Healthcare Contracts: Tensions Between Standardisation and Innovation; Comment on “Competition in Healthcare: Good, Bad or Ugly?” [PDF]

open access: yesInternational Journal of Health Policy and Management, 2016
An important determinant of health system performance is contracting. Providers often respond to financial incentives, despite the ethical underpinnings of medicine, and payers can craft contracts to influence performance.
Misja Mikkers, Padhraig Ryan
doaj   +1 more source

Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands [PDF]

open access: yesInternational Journal of Health Policy and Management, 2023
Background  Purchasing systems aim to improve resource allocation in healthcare markets. The Netherlands is characterized by four different purchasing systems: managed competition in the hospital market, a non-competitive single payer system for long ...
Niek Stadhouders   +4 more
doaj   +1 more source

Socioeconomic Status and Kawasaki Disease Outcomes in a Single-Payer Health Care System

open access: yesCJC Pediatric and Congenital Heart Disease, 2022
Background: For patients with Kawasaki disease (KD), lower socioeconomic status (SES) may adversely affect the timeliness of presentation and initiation of intravenous immune globulin, and coronary artery outcomes.
Jonathan P. Wong, MD   +8 more
doaj   +1 more source

How COVID has Illuminated the Pitfalls of a Single-Payer System in the US

open access: yesMarshall Journal of Medicine, 2020
Health care quality measures are impacted by resources invested into outcomes. COVID-19 has had a direct impact upon quality outcomes, the same illuminating just some of the problems with the concept of a single-payer health care system.
Tamela J. White, Nicholas Wright
doaj   +1 more source

Disparity in clinical outcomes after cardiac surgery between private and public (NHS) payers in England

open access: yesThe Lancet Regional Health. Europe, 2021
Background: There is little known about how payer status impacts clinical outcomes in a universal single-payer system such as the UK National Health Service (NHS).
Umberto Benedetto   +13 more
doaj   +1 more source

Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses.

open access: yesPLoS Medicine, 2020
BackgroundThe United States is the only high-income nation without universal, government-funded or -mandated health insurance employing a unified payment system.
Christopher Cai   +8 more
doaj   +1 more source

Does Universal Health Insurance in Korea provide a Lesson for U.S. Health Care Financing?

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2023
This note provides a commentary on Lee, C. “Is Universal Health Insurance Superior in Terms of Healthcare Payment? Estimating the Financial Burden of Healthcare in Korea: 2009 to 2019.” INQUIRY, 2022, 59:1-8.
Phillip Phan PhD
doaj   +1 more source

Public–private partnership alternative for a national pharmacare program in Canada

open access: yesJournal of Pharmaceutical Policy and Practice, 2023
Background Recently, the government and an opposition party cut a deal that involved a promise to consider implementing a single-payer pharmacare scheme in Canada in exchange for supporting the current minority government.
Eric Nauenberg, Emre Yurga
doaj   +1 more source

Financing of Public Health Care for the Population of the Russian Federation: To Maintain Multichannel or Switch to a Single Payer System?

open access: yesФинансы: теория и практика, 2022
The subject of the research is the models of collection and consolidation (pooling) of resources for payment of public (free at the place of delivery) medical care to the population in developed countries and in the Russian Federation. The purpose of the
A. L. Safonov   +2 more
doaj   +1 more source

Prevalence and health care costs of mitochondrial disease in Ontario, Canada: A population-based cohort study.

open access: yesPLoS ONE, 2022
BackgroundMitochondrial disease prevalence has been estimated at 1 in 4000 in the United States, and 1 in 5000 worldwide. Prevalence in Canada has not been established, though multi-linked health administrative data resources present a unique opportunity
Emmalin Buajitti   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy